{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:38:56Z","timestamp":1790901536229,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,2,23]],"date-time":"2006-02-23T00:00:00Z","timestamp":1140652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,2,23]],"date-time":"2006-02-23T00:00:00Z","timestamp":1140652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1038\/sj.leu.2404144","type":"journal-article","created":{"date-parts":[[2006,2,23]],"date-time":"2006-02-23T14:12:58Z","timestamp":1140703978000},"page":"680-688","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Thymidine-phosphorothioate oligonucleotides induce activation and apoptosis of CLL cells independently of CpG motifs or BCL-2 gene interference"],"prefix":"10.1038","volume":"20","author":[{"given":"J E","family":"Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C E","family":"Prada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"Aguillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kitada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Dicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Y J","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J C","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T J","family":"Kipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,2,23]]},"reference":[{"key":"BF2404144_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/372333a0","volume":"372","author":"RW Wagner","year":"1994","unstructured":"Wagner RW . Gene inhibition using antisense oligodeoxynucleotides. Nature 1994; 372: 333\u2013335.","journal-title":"Nature"},{"key":"BF2404144_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/nar\/7.1.179","volume":"7","author":"H Donis-Keller","year":"1979","unstructured":"Donis-Keller H . Site specific enzymatic cleavage of RNA. Nucleic Acids Res 1979; 7: 179\u2013192.","journal-title":"Nucleic Acids Res"},{"key":"BF2404144_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1146\/annurev.med.55.091902.104408","volume":"55","author":"ST Crooke","year":"2004","unstructured":"Crooke ST . Progress in antisense technology. Annu Rev Med 2004; 55: 61\u201395.","journal-title":"Annu Rev Med"},{"key":"BF2404144_CR4","first-page":"118","volume":"5","author":"AC Stephens","year":"2003","unstructured":"Stephens AC, Rivers RP . Antisense oligonucleotide therapy in cancer. Curr Opin Mol Ther 2003; 5: 118\u2013122.","journal-title":"Curr Opin Mol Ther"},{"key":"BF2404144_CR5","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1182\/blood.V82.6.1820.1820","volume":"82","author":"M Hanada","year":"1993","unstructured":"Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC . bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 1993; 82: 1820\u20131828.","journal-title":"Blood"},{"key":"BF2404144_CR6","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1200\/JCO.1999.17.9.2941","volume":"17","author":"JC Reed","year":"1999","unstructured":"Reed JC . Dysregulation of apoptosis in cancer. J Clin Oncol 1999; 17: 2941\u20132953.","journal-title":"J Clin Oncol"},{"key":"BF2404144_CR7","first-page":"6565","volume":"50","author":"JC Reed","year":"1990","unstructured":"Reed JC, Stein C, Subasinghe C, Haldar S, Croce CM, Yum S et al. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Res 1990; 50: 6565\u20136570.","journal-title":"Cancer Res"},{"key":"BF2404144_CR8","first-page":"3049","volume":"9","author":"FE Cotter","year":"1994","unstructured":"Cotter FE, Johnson P, Hall P, Pocock C, al Mahdi N, Cowell JK et al. Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model. Oncogene 1994; 9: 3049\u20133055.","journal-title":"Oncogene"},{"key":"BF2404144_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/108729002760220798","volume":"12","author":"RJ Klasa","year":"2002","unstructured":"Klasa RJ, Gillum AM, Klem RE, Frankel SR . Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatment. Antisense Nucleic Acid Drug Dev 2002; 12: 193\u2013213.","journal-title":"Antisense Nucleic Acid Drug Dev"},{"key":"BF2404144_CR10","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1200\/JCO.2004.10.148","volume":"22","author":"CM Rudin","year":"2004","unstructured":"Rudin CM, Kozloff M, Hoffman PC, Edelman MJ, Karnauskas R, Tomek R et al. Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer. J Clin Oncol 2004; 22: 1110\u20131117.","journal-title":"J Clin Oncol"},{"key":"BF2404144_CR11","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1200\/JCO.2005.09.118","volume":"23","author":"G Marcucci","year":"2005","unstructured":"Marcucci G, Stock W, Dai G, Klisovic RB, Liu S, Klisovic MI et al. Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity. J Clin Oncol 2005; 23: 3404\u20133411.","journal-title":"J Clin Oncol"},{"key":"BF2404144_CR12","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1158\/1078-0432.CCR-04-2145","volume":"11","author":"AW Tolcher","year":"2005","unstructured":"Tolcher AW, Chi K, Kuhn J, Gleave M, Patnaik A, Takimoto C et al. A phase II, pharmacokinetic, and biological correlative study of oblimersen sodium and docetaxel in patients with hormone-refractory prostate cancer. Clin Cancer Res 2005; 11: 3854\u20133861.","journal-title":"Clin Cancer Res"},{"key":"BF2404144_CR13","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1093\/jnci\/89.14.988","volume":"89","author":"JC Reed","year":"1997","unstructured":"Reed JC . Promise and problems of Bcl-2 antisense therapy. J Natl Cancer Inst 1997; 89: 988\u2013990.","journal-title":"J Natl Cancer Inst"},{"key":"BF2404144_CR14","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/374546a0","volume":"374","author":"AM Krieg","year":"1995","unstructured":"Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995; 374: 546\u2013549.","journal-title":"Nature"},{"key":"BF2404144_CR15","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1172\/JCI1472","volume":"101","author":"K Kato","year":"1998","unstructured":"Kato K, Cantwell MJ, Sharma S, Kipps TJ . Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells. J Clin Invest 1998; 101: 1133\u20131141.","journal-title":"J Clin Invest"},{"key":"BF2404144_CR16","first-page":"1640","volume":"8","author":"E Matutes","year":"1994","unstructured":"Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994; 8: 1640\u20131645.","journal-title":"Leukemia"},{"key":"BF2404144_CR17","first-page":"420","volume":"281","author":"FI Raynaud","year":"1997","unstructured":"Raynaud FI, Orr RM, Goddard PM, Lacey HA, Lancashire H, Judson IR et al. Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice. J Pharmacol Exp Ther 1997; 281: 420\u2013427.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF2404144_CR18","first-page":"1463a","volume":"100","author":"JE Castro","year":"2002","unstructured":"Castro JE, Motta M, Wu C, Carson DA, Kipps TJ . Phosphorothioate oligodeoxynucleotides activate chronic lymphocytic leukemia B cells through a CpG independent mechanism. Blood 2002; 100: 1463a.","journal-title":"Blood"},{"key":"BF2404144_CR19","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1089\/104303403765701141","volume":"14","author":"CC Wu","year":"2003","unstructured":"Wu CC, Castro JE, Motta M, Cottam HB, Kyburz D, Kipps TJ et al. Selection of oligonucleotide aptamers with enhanced uptake and activation of human leukemia B cells. Hum Gene Ther 2003; 14: 849\u2013860.","journal-title":"Hum Gene Ther"},{"key":"BF2404144_CR20","first-page":"515","volume":"145","author":"S Krajewski","year":"1994","unstructured":"Krajewski S, Bodrug S, Gascoyne R, Berean K, Krajewska M, Reed JC . Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. Am J Pathol 1994; 145: 515\u2013525.","journal-title":"Am J Pathol"},{"key":"BF2404144_CR21","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1182\/blood.V96.12.3922","volume":"96","author":"PA Svingen","year":"2000","unstructured":"Svingen PA, Karp JE, Krajewski S, Mesner Jr PW, Gore SD, Burke PJ et al. Evaluation of Apaf-1, and procaspases-2, -3, -7, -8, and -9 as potential prognostic markers in acute leukemia. Blood 2000; 96: 3922\u20133931.","journal-title":"Blood"},{"key":"BF2404144_CR22","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1073\/pnas.022604399","volume":"99","author":"P Chu","year":"2002","unstructured":"Chu P, Deforce D, Pedersen IM, Kim Y, Kitada S, Reed JC et al. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 3854\u20133859.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2404144_CR23","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1182\/blood.V88.12.4676.bloodjournal88124676","volume":"88","author":"MJ Cantwell","year":"1996","unstructured":"Cantwell MJ, Sharma S, Friedmann T, Kipps TJ . Adenovirus vector infection of chronic lymphocytic leukemia B cells. Blood 1996; 88: 4676\u20134683.","journal-title":"Blood"},{"key":"BF2404144_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1034\/j.1600-065X.2000.00606.x","volume":"176","author":"N Baumgarth","year":"2000","unstructured":"Baumgarth N . A two-phase model of B-cell activation. Immunol Rev 2000; 176: 171\u2013180.","journal-title":"Immunol Rev"},{"key":"BF2404144_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.clim.2003.11.017","volume":"110","author":"E Morgan","year":"2004","unstructured":"Morgan E, Varro R, Sepulveda H, Ember JA, Apgar J, Wilson J et al. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin Immunol 2004; 110: 252\u2013266.","journal-title":"Clin Immunol"},{"key":"BF2404144_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0378-4274(96)03729-0","volume":"88","author":"M Radloff","year":"1996","unstructured":"Radloff M, Gercken G . Protein kinase C activity and phosphoprotein pattern in stimulated alveolar macrophages. Toxicol Lett 1996; 88: 139\u2013145.","journal-title":"Toxicol Lett"},{"key":"BF2404144_CR27","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/S0021-9258(17)37680-9","volume":"269","author":"CJ Vlahos","year":"1994","unstructured":"Vlahos CJ, Matter WF, Hui KY, Brown RF . A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994; 269: 5241\u20135248.","journal-title":"J Biol Chem"},{"key":"BF2404144_CR28","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1073\/pnas.90.10.4674","volume":"90","author":"KA Qatsha","year":"1993","unstructured":"Qatsha KA, Rudolph C, Marme D, Schachtele C, May WS . Go 6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent\/low-level-producing reservoir cells in vitro. Proc Natl Acad Sci USA 1993; 90: 4674\u20134678.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2404144_CR29","first-page":"100","volume":"56","author":"E Buchdunger","year":"1996","unstructured":"Buchdunger E, Zimmermann J, Mett H, Meyer T, Muller M, Druker BJ et al. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res 1996; 56: 100\u2013104.","journal-title":"Cancer Res"},{"key":"BF2404144_CR30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S1570-0232(01)00611-0","volume":"768","author":"R Bakhtiar","year":"2002","unstructured":"Bakhtiar R, Lohne J, Ramos L, Khemani L, Hayes M, Tse F . High-throughput quantification of the anti-leukemia drug STI571 (Gleevec) and its main metabolite (CGP 74588) in human plasma using liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 768: 325\u2013340.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"BF2404144_CR31","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1046\/j.1365-2141.1999.01726.x","volume":"107","author":"C Pepper","year":"1999","unstructured":"Pepper C, Thomas A, Hoy T, Cotter F, Bentley P . Antisense-mediated suppression of Bcl-2 highlights its pivotal role in failed apoptosis in B-cell chronic lymphocytic leukaemia. Br J Haematol 1999; 107: 611\u2013615.","journal-title":"Br J Haematol"},{"key":"BF2404144_CR32","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1158\/1078-0432.CCR-03-0287","volume":"10","author":"A Raffo","year":"2004","unstructured":"Raffo A, Lai JC, Stein CA, Miller P, Scaringe S, Khvorova A et al. Antisense RNA down-regulation of bcl-2 expression in DU145 prostate cancer cells does not diminish the cytostatic effects of G3139 (Oblimersen). Clin Cancer Res 2004; 10: 3195\u20133206.","journal-title":"Clin Cancer Res"},{"key":"BF2404144_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1471-4906(01)02150-0","volume":"23","author":"AM Krieg","year":"2002","unstructured":"Krieg AM . From A to Z on CpG. Trends Immunol 2002; 23: 64\u201365.","journal-title":"Trends Immunol"},{"key":"BF2404144_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1089\/108729002760220761","volume":"12","author":"J Vollmer","year":"2002","unstructured":"Vollmer J, Janosch A, Laucht M, Ballas ZK, Schetter C, Krieg AM . Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes. Antisense Nucleic Acid Drug Dev 2002; 12: 165\u2013175.","journal-title":"Antisense Nucleic Acid Drug Dev"},{"key":"BF2404144_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S1535-6108(02)00241-6","volume":"3","author":"JC Reed","year":"2003","unstructured":"Reed JC . Apoptosis-targeted therapies for cancer. Cancer Cell 2003; 3: 17\u201322.","journal-title":"Cancer Cell"},{"key":"BF2404144_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1023\/A:1006175811676","volume":"55","author":"LF Gibson","year":"1999","unstructured":"Gibson LF, Fortney J, Magro G, Ericson SG, Lynch JP, Landreth KS . Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy. Breast Cancer Res Treat 1999; 55: 107\u2013117.","journal-title":"Breast Cancer Res Treat"},{"key":"BF2404144_CR37","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/j.1572-0241.2002.05528.x","volume":"97","author":"SS Husain","year":"2002","unstructured":"Husain SS, Szabo IL, Tamawski AS . NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action. Am J Gastroenterol 2002; 97: 542\u2013553.","journal-title":"Am J Gastroenterol"},{"key":"BF2404144_CR38","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/sj.cdd.4400938","volume":"8","author":"JY Wang","year":"2001","unstructured":"Wang JY . DNA damage and apoptosis. Cell Death Differ 2001; 8: 1047\u20131048.","journal-title":"Cell Death Differ"},{"key":"BF2404144_CR39","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S0959-8049(03)00063-7","volume":"39","author":"S Lain","year":"2003","unstructured":"Lain S, Lane D . Improving cancer therapy by non-genotoxic activation of p53. Eur J Cancer 2003; 39: 1053\u20131060.","journal-title":"Eur J Cancer"},{"key":"BF2404144_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3835(01)00698-X","volume":"174","author":"O Pluquet","year":"2001","unstructured":"Pluquet O, Hainaut P . Genotoxic and non-genotoxic pathways of p53 induction. Cancer Lett 2001; 174: 1\u201315.","journal-title":"Cancer Lett"},{"key":"BF2404144_CR41","doi-asserted-by":"publisher","first-page":"4438","DOI":"10.1128\/MCB.24.10.4438-4447.2004","volume":"24","author":"BN Chau","year":"2004","unstructured":"Chau BN, Chen TT, Wan YY, DeGregori J, Wang JY . Tumor necrosis factor alpha-induced apoptosis requires p73 and c-ABL activation downstream of RB degradation. Mol Cell Biol 2004; 24: 4438\u20134447.","journal-title":"Mol Cell Biol"},{"key":"BF2404144_CR42","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.1038\/sj.onc.1203878","volume":"19","author":"JY Wang","year":"2000","unstructured":"Wang JY . Regulation of cell death by the Abl tyrosine kinase. Oncogene 2000; 19: 5643\u20135650.","journal-title":"Oncogene"},{"key":"BF2404144_CR43","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1093\/emboj\/cdf384","volume":"21","author":"Z Goldberg","year":"2002","unstructured":"Goldberg Z, Vogt Sionov R, Berger M, Zwang Y, Perets R, Van Etten RA et al. Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation. EMBO J 2002; 21: 3715\u20133727.","journal-title":"EMBO J"},{"key":"BF2404144_CR44","doi-asserted-by":"publisher","first-page":"25151","DOI":"10.1074\/jbc.M301962200","volume":"278","author":"V Vella","year":"2003","unstructured":"Vella V, Zhu J, Frasca F, Li CY, Vigneri P, Vigneri R et al. Exclusion of c-Abl from the nucleus restrains the p73 tumor suppression function. J Biol Chem 2003; 278: 25151\u201325157.","journal-title":"J Biol Chem"},{"key":"BF2404144_CR45","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/21690","volume":"399","author":"JG Gong","year":"1999","unstructured":"Gong JG, Costanzo A, Yang HQ, Melino G, Kaelin Jr WG, Levrero M et al. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 1999; 399: 806\u2013809.","journal-title":"Nature"},{"key":"BF2404144_CR46","doi-asserted-by":"publisher","first-page":"10281","DOI":"10.1073\/pnas.1635435100","volume":"100","author":"T Truong","year":"2003","unstructured":"Truong T, Sun G, Doorly M, Wang JY, Schwartz MA . Modulation of DNA damage-induced apoptosis by cell adhesion is independently mediated by p53 and c-Abl. Proc Natl Acad Sci USA 2003; 100: 10281\u201310286.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2404144_CR47","doi-asserted-by":"publisher","first-page":"16992","DOI":"10.1074\/jbc.M300039200","volume":"278","author":"X Yi","year":"2003","unstructured":"Yi X, Yin XM, Dong Z . Inhibition of Bid-induced apoptosis by Bcl-2. tBid insertion, Bax translocation, and Bax\/Bak oligomerization suppressed. J Biol Chem 2003; 278: 16992\u201316999.","journal-title":"J Biol Chem"},{"key":"BF2404144_CR48","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1101\/gad.10.22.2859","volume":"10","author":"K Wang","year":"1996","unstructured":"Wang K, Yin XM, Chao DT, Milliman CL, Korsmeyer SJ . BID: a novel BH3 domain-only death agonist. Genes Dev 1996; 10: 2859\u20132869.","journal-title":"Genes Dev"},{"key":"BF2404144_CR49","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/ncb1123","volume":"6","author":"JI Leu","year":"2004","unstructured":"Leu JI, Dumont P, Hafey M, Murphy ME, George DL . Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 2004; 6: 443\u2013450.","journal-title":"Nat Cell Biol"},{"key":"BF2404144_CR50","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.1092734","volume":"303","author":"JE Chipuk","year":"2004","unstructured":"Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004; 303: 1010\u20131014.","journal-title":"Science"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404144","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:17:39Z","timestamp":1648775859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,23]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["BF2404144"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404144","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,23]]},"assertion":[{"value":"10 October 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2005","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}